Publications
Specialty
Search
Pharmacy Learning Network
09/26/2024
Which significant difference between donanemab and lecanemab was mentioned in the Phase III TRAILBLAZER-ALZ 2 study?
Neurology
09/26/2024
Adding the anti-clotting drugs argatroban or eptifibatide to routine intravenous thrombolysis treatment in patients with acute ischemic stroke did not reduce poststroke disability, and was associated with an increase in mortality.
Psych Congress Network
09/26/2024
A once-daily, 20 mg dose of an investigational oral muscarinic M4 selective agonist in development for adults with schizophrenia achieved its primary endpoint in a phase 2 trial, maker Neurocrine Biosciences announced.
ePlasty, Surgery
09/26/2024
This study reviewed pediatric burn patients treated with dermal substrates, assessing wound healing and complications following dermal substrate application and grafting.
IO Learning
09/26/2024
Elena Violari, MD, RPVI, discusses irreversible electroporation for pancreatic cancer with Govindarajan Narayanan, MD, in the latest episode of the SIO Corner podcast.
First Report Managed Care
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Oncology
09/26/2024
According to results from a phase 2 study, odronextamab therapy achieved deep and durable responses among pretreated patients with relapsed/refractory follicular lymphoma, while demonstrating a manageable safety profile.
Oncology
09/26/2024
Patients with triple class exposed/refractory multiple myeloma treated with belantamab mafodotin plus pomalidomide-dexamethasone achieved high clinical response rates with durable remissions, determined a post-hoc analysis of the ALGONQUIN trial.
Psych Congress NP Institute
09/26/2024
Explore the current challenges in treating MDD in a discussion with Brooke Kempf, MSN, PMHNP-BC, and Rakesh Jain, MD, MPH.
Journal of Clinical Pathways
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Pharmacy Learning Network
09/26/2024
What does ARIA-E stand for in Alzheimer disease treatment?
Vascular Disease Management, CardioVascular
09/26/2024
This literature review investigates the incidence, etiology, and treatment strategies for spontaneous hemothorax in patients with neurofibromatosis type 1 (NF1).
Integrated Healthcare Executive
09/26/2024
“The standardized frequency of medical procedures and drugs prescribed in patients with post-vaccine myocarditis or post-COVID-19 myocarditis followed a similar trend in the 18 months following hospital discharge to that of patients with conventional myocarditis,” researchers reported.
Vascular Disease Management, CardioVascular
09/26/2024
Medical abbreviations play a vital role in the work and research that goes on in a hospital. However, there can be a certain amount of confusion associated with their use. The authors conducted a survey among radiology doctors to assess their opinions about abbreviations used in the field of IR.
EMSWorld
09/26/2024
The field of hemorrhage control is experiencing rapid advancements, particularly in the area of abdominal bleeding. And on this episode of the EMS World Podcasts, we'll be taking a look at one product in particular—the AAJT-S tourniquet.
Live from the exhibit floor at EMS World Expo 2024, host Mike McCabe is joined by Dr. John Croushorn, an emergency medicine physician in Birmingham, Alabama, to explore this innovative abdominal tourniquet.
First Report Managed Care
09/25/2024
Explore the state of siRNA-based therapies, relevant pharmacology insights, and care strategies aimed to enhance patient outcomes.
Oncology
09/25/2024
Based on results from the LAURA trial, the FDA has approved osimertinib for patients with locally advanced, unresectable non-small lung cancer harboring EGFR mutations who do not experience disease progression on or after concurrent or sequential platinum-based chemoradiation.
EMSWorld
09/25/2024
The Xtension Pro Neonatal is designed to secure a Dräger incubator and accommodate diverse medical device configurations on a Stryker Power-Pro 2 Stretcher.
Oncology
09/25/2024
According to exploratory results from the phase 3 KRYSTAL-12 trial, adagrasib improved efficacy outcomes among patients with previously treated KRAS G12C-mutated advanced non-small cell lung cancer, regardless of the presence of baseline brain metastases.
Integrated Healthcare Executive
09/25/2024
Faisal Pandit, VP and GM at Johnson Controls Security Products, discusses the importance of scalability, cloud-first transformation, and cybersecurity tactics in improving user experience and security in health care settings.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
